{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:47Z","timestamp":1786980527482,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10120-017-0697-6","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T11:19:12Z","timestamp":1488194352000},"page":"784-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer"],"prefix":"10.1007","volume":"20","author":[{"given":"Hideki","family":"Ushiku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Minatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuya","family":"Katada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-7371","authenticated-orcid":false,"given":"Masahiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"697_CR1","unstructured":"International Agency for Research on Cancer WHO (2012) GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence.\u00a0\n                        http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx\n                        \n                    . Accessed 27 Feb 2017"},{"key":"697_CR2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. ACTS-GC Group, Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810\u201320.","journal-title":"N Engl J Med"},{"key":"697_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10120-008-0466-7","volume":"11","author":"K Yamashita","year":"2008","unstructured":"Yamashita K, Sakuramoto S, Kikuchi S, Katada N, Kobayashi N, Watanabe M. Validation of staging systems for gastric cancer. Gastric Cancer. 2008;11:111\u20138.","journal-title":"Gastric Cancer"},{"key":"697_CR4","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.3748\/wjg.v17.i29.3390","volume":"17","author":"K Yamashita","year":"2001","unstructured":"Yamashita K, Sakuramoto S, Nemoto M, Shibata T, Mieno H, Katada N, et al. Trend in gastric cancer: 35\u00a0years of surgical experience in Japan. World J Gastroenterol. 2001;17:3390\u20137.","journal-title":"World J Gastroenterol"},{"key":"697_CR5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00595-014-1060-8","volume":"45","author":"K Hosoda","year":"2015","unstructured":"Hosoda K, Yamashita K, Katada N, Moriya H, Mieno H, Sakuramoto S, et al. Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer. Surg Today. 2015;45:68\u201377.","journal-title":"Surg Today"},{"key":"697_CR6","first-page":"897","volume":"35","author":"K Yamashita","year":"2015","unstructured":"Yamashita K, Hosoda K, Katada N, Moriya H, Mieno H, Higuchi K, et al. Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment. Anticancer Res. 2015;35:897\u2013906.","journal-title":"Anticancer Res"},{"key":"697_CR7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00595-012-0388-1","volume":"43","author":"K Yamashita","year":"2013","unstructured":"Yamashita K, Sakuramoto S, Shibata T, Nemoto M, Mieno H, Katada N, et al. Survival outcome of laparoscopic gastrectomy for clinical early (cT1) gastric cancer. Surg Today. 2013;43:1013\u20138.","journal-title":"Surg Today"},{"key":"697_CR8","first-page":"512","volume":"61","author":"K Yamashita","year":"2014","unstructured":"Yamashita K, Sakuramoto S, Katada N, Kikuchi S, Watanabe M. Simple prognostic indicators using macroscopic features and age in advanced gastric cancer. Hepatogastroenterology. 2014;61:512\u20137.","journal-title":"Hepatogastroenterology"},{"key":"697_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/PL00011681","volume":"1","author":"Association JGC","year":"1998","unstructured":"Association JGC. Japanese classification of gastric carcinoma\u20142nd English edition. Gastric Cancer. 1998;1:10\u201324.","journal-title":"Gastric Cancer"},{"key":"697_CR10","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.27707","volume":"61","author":"K Andresen","year":"2015","unstructured":"Andresen K, Boberg K, Vedeld HM, Honne H, Jebsen P, Hektoen M, et al. Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Hepatology. 2015;61:1651\u20139.","journal-title":"Hepatology"},{"key":"697_CR11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00268-009-0355-1","volume":"34","author":"T Fukagawa","year":"2010","unstructured":"Fukagawa T, Katai H, Saka M, Morita S, Sasajima Y, Taniguchi H, et al. Significance of lavage cytology in advanced gastric cancer patients. World J Surg. 2010;34:563\u20138.","journal-title":"World J Surg"},{"key":"697_CR12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/bjs.7812","volume":"99","author":"SD Lee","year":"2012","unstructured":"Lee SD, Ryu KW, Eom BW, Lee JH, Kook MC, Kim YW. Prognostic significance of peritoneal washing cytology in patients with gastric cancer. Br J Surg. 2012;99:397\u2013403.","journal-title":"Br J Surg"},{"key":"697_CR13","volume-title":"TNM classification of malignant tumours","author":"IUA Cancer","year":"2009","unstructured":"Cancer IUA. TNM classification of malignant tumours. 7th ed. NewYork: Wiley-Blackwell; 2009.","edition":"7"},{"key":"697_CR14","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1245\/s10434-010-1183-0","volume":"17","author":"JJ Mezhir","year":"2010","unstructured":"Mezhir JJ, Shah MA, Jacks LM, Brennan MF, Coit DG, Strong VE. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol. 2010;17:3173\u201380.","journal-title":"Ann Surg Oncol"},{"key":"697_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00000658-200204000-00007","volume":"235","author":"Y Kodera","year":"2002","unstructured":"Kodera Y, Nakanishi H, Ito S, Yamamura Y, Kanemitsu Y, Shimizu Y, et al. Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: a sensitive predictor of outcome for patients with gastric carcinoma. Ann Surg. 2002;235:499\u2013506.","journal-title":"Ann Surg"},{"key":"697_CR16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1535-6108(02)00215-5","volume":"2","author":"K Yamashita","year":"2002","unstructured":"Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell. 2002;2:485\u201395.","journal-title":"Cancer Cell"},{"key":"697_CR17","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1158\/0008-5472.CAN-05-1511","volume":"66","author":"K Yamashita","year":"2006","unstructured":"Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, et al. PGP9.5 methylation in diffuse-type gastric cancer. Cancer Res. 2006;66:3921\u20137.","journal-title":"Cancer Res"},{"key":"697_CR18","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1158\/0008-5472.CAN-05-1608","volume":"66","author":"MS Kim","year":"2006","unstructured":"Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, Osada M, et al. N-methyl-d-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res. 2006;66:3409\u201318.","journal-title":"Cancer Res"},{"key":"697_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/1541-7786.MCR-07-0213","volume":"6","author":"K Yamashita","year":"2008","unstructured":"Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, et al. HOP\/OB1\/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Mol Cancer Res. 2008;6:31\u201341.","journal-title":"Mol Cancer Res"},{"key":"697_CR20","doi-asserted-by":"crossref","first-page":"e44951","DOI":"10.1371\/journal.pone.0044951","volume":"7","author":"M Brait","year":"2012","unstructured":"Brait M, Ling S, Nagpal JK, Chang X, Park HL, Lee J, et al. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS One. 2012;7:e44951.","journal-title":"PLoS One"},{"key":"697_CR21","doi-asserted-by":"crossref","first-page":"e113546","DOI":"10.1371\/journal.pone.0113546","volume":"9","author":"K Yamashita","year":"2014","unstructured":"Yamashita K, Waraya M, Kim MS, Sidransky D, Katada N, Sato T, et al. Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study. PLoS One. 2014;9:e113546.","journal-title":"PLoS One"},{"key":"697_CR22","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1158\/1078-0432.CCR-12-3751","volume":"19","author":"J Jeschke","year":"2013","unstructured":"Jeschke J, O\u2019Hagan HM, Zhang W, Vatapalli R, Calmon MF, Danilova L, et al. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clin Cancer Res. 2013;19:3201\u201311.","journal-title":"Clin Cancer Res"},{"key":"697_CR23","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-13-2109","volume":"20","author":"J Wrangle","year":"2014","unstructured":"Wrangle J, Machida EO, Danilova L, Hulbert A, Franco N, Zhang W, et al. Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer. Clin Cancer Res. 2014;20:1856\u201364.","journal-title":"Clin Cancer Res"},{"key":"697_CR24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.29039","volume":"136","author":"HM Vedeld","year":"2015","unstructured":"Vedeld HM, Andresen K, Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, et al. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers. Int J Cancer. 2015;136:844\u201353.","journal-title":"Int J Cancer"},{"key":"697_CR25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-14-1656","volume":"21","author":"A Feber","year":"2015","unstructured":"Feber A, Arya M, de Winter P, Saqib M, Nigam R, Malone PR, et al. Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer. Clin Cancer Res. 2015;21:1196\u2013206.","journal-title":"Clin Cancer Res"},{"key":"697_CR26","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1158\/1078-0432.CCR-14-2049","volume":"21","author":"IA Deckers","year":"2015","unstructured":"Deckers IA, Schouten LJ, Van Neste L, van Vlodrop IJ, Soetekouw PM, Baldewijns MM, et al. Promoter methylation of CDO1 identifies clear-cell renal cell cancer patients with poor survival outcome. Clin Cancer Res. 2015;21:3492\u2013500.","journal-title":"Clin Cancer Res"},{"key":"697_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Association JGC","year":"2011","unstructured":"Association JGC. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101\u201312.","journal-title":"Gastric Cancer"},{"key":"697_CR28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00280-011-1701-1","volume":"69","author":"W Koizumi","year":"2012","unstructured":"Koizumi W, Nakayama N, Tanabe S, Sasaki T, Higuchi K, Nishimura K, et al. A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601). Cancer Chemother Pharmacol. 2012;69:407\u201313.","journal-title":"Cancer Chemother Pharmacol"},{"key":"697_CR29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ejso.2015.05.021","volume":"41","author":"K Yamashita","year":"2015","unstructured":"Yamashita K, Ushiku H, Katada N, Hosoda K, Moriya H, Mieno H, et al. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test. Eur J Surg Oncol. 2015;41:1324\u201332.","journal-title":"Eur J Surg Oncol"},{"key":"697_CR30","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1245\/s10434-011-1636-0","volume":"18","author":"M Hiraki","year":"2011","unstructured":"Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, et al. Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cacner patients. Ann Surg Oncol. 2011;18:3013\u20139.","journal-title":"Ann Surg Oncol"},{"key":"697_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000151613","volume":"75","author":"N Nakayama","year":"2008","unstructured":"Nakayama N, Koizumi W, Sasaki T, Higuchi K, Tanabe S, Nishimura K, et al. A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601). Oncology. 2008;75:1\u20137.","journal-title":"Oncology"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-017-0697-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-017-0697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-017-0697-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T14:19:03Z","timestamp":1503411543000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-017-0697-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["697"],"URL":"https:\/\/doi.org\/10.1007\/s10120-017-0697-6","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}